HUmanitas PROtontherapy (HU-PRO)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIstituto Clinico Humanitas

About this trial

Proton therapy is a cancer treatment, similar to the more commonly used radiation therapy. It uses radiation to destroy cancer cells and helps control the disease in the treated area.

However, when proton therapy is compared with standard radiation therapy, many studies show fewer side effects and better disease control. This is due to the unique physical properties of the particles used in proton therapy.

At present, in Italy, this innovative treatment is available only for selected diseases, as defined by national guidelines. For this reason, it is very important to collect as much data as possible to support the further development of proton therapy and to improve treatment safety and effectiveness.

Eligibility criteria

Qualifiers

Solid tumors candidate to proton therapy, in particular, according to Italian regolamentations

Written informed consent for HU-PRO according to applicable legal and ethical requirements

Indication for proton therapy

≥ 18 years old

Disqualifiers

Age < 18 years old

ECOG (performance status scale) >3

Life expectancy < 3 months

Inability to provide informed consent

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

500 Participants
are grouped into 1 trial group

Sponsors and collaborators